![Tongle Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tongle Yu
Directeur/Bestuurslid bij
Jiangsu Highlight Equity Investment Management Co. Ltd.
Profiel
Tongle Yu is currently a Partner at Jiangsu Highlight Equity Investment Management Co. Ltd. Previously, he worked as a Non-Executive Director at Biosino Bio-Technology & Science, Inc. from 2013 to 2015.
He obtained his undergraduate degree from Fudan University.
Actieve functies van Tongle Yu
| Bedrijven | Functie | Begin |
|---|---|---|
Jiangsu Highlight Equity Investment Management Co. Ltd.
 Jiangsu Highlight Equity Investment Management Co. Ltd. Investment ManagersFinance Highlight Capital is an active asset manager that provides equity financing for early and growth stage capital requirements. The firm targets companies operating in the biopharmaceutical, medical technology and consumer health sectors. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Tongle Yu
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Directeur/Bestuurslid | 03-03-2015 |
Opleiding van Tongle Yu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Biosino Bio-Technology & Science, Inc.
 Biosino Bio-Technology & Science, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes in-vitro diagnostic reagent | Health Technology |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Highlight Equity Investment Management Co. Ltd.
Jiangsu Highlight Equity Investment Management Co. Ltd. Investment ManagersFinance Highlight Capital is an active asset manager that provides equity financing for early and growth stage capital requirements. The firm targets companies operating in the biopharmaceutical, medical technology and consumer health sectors. | Finance |
